A Jourdes, E Cellerin, C Touzeau, S Harel… - Clinical Microbiology …, 2024 - Elsevier
Abstract Objectives Bispecific antibodies (BsAbs) are an effective treatment used in relapsed
or refractory multiple myeloma. Despite a well-tolerated safety profile, infectious events …